Found 0 matching trials
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
PHASE1This phase Ⅰ/Ⅱ trial is designed to explore a higher radiation dose by usin...
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
PHASE2In a single-center, prospective, phase II study (ClinicalTrials registratio...
Location
The First Affiliated Hospital of Wenzhou Medical University
Efficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction
PHASE2Investigators conduct the clinical trial to further explore the efficacy an...
Location
Peking Union Medical College Hospital
The dıagnostıc Value of Serum autotaxın Level ın Colorectal Cancer
N/AColorectal cancer is one of the most common causes of cancer-related death....
Location
Dışkapı Yıldırım Beyazıt training and research hospital
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
PHASE2This is a phase II trial of neoadjuvant and adjuvant atezolizumab with or w...
Status
Active Not Recruiting
Location
University of California San Diego Moores Cancer Center
a Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients
N/AThis study is aimed to develop a genome-based platform to predict patients ...
Location
Yonsei Severance Hospital
Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer
NARATIONALE: Surgical resection and adjuvant therapy has become the main trea...
Location
Gastrointestinal Hospital, Sun Yat-sen University
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
N/AThe goal of this prospective, observational study is to explore the value o...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of USTC / Anhui Provincial Hospital
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
PHASE3This open-label, multicenter, randomized controlled trial involved 154 pati...
Location
Multiple Locations
Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer
PHASE1Irinotecan is one of effective drugs for colorectal cancer. In neoadjuvant ...
Location
Cancer Hospital, Fudan University